Audit to prepare for eventual sales into the US market SALT LAKE CITY CODX, (BUSINESS WIRE) Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company with a unique, proprietary platform for the development of diagnostic tests, will be undergoing a Stage II Upgrade Assessment Audit to ISO 13485:2016. The International Organization of Standards (ISO) is a non-government entity comprised of academic and industry professionals which certifies that companies are compliant with industry-standard best practices in their production and operations.
http://bit.ly/2usOXaO
No comments:
Post a Comment